Results 1 to 10 of about 44,297 (184)
Enhanced Topical Treatment of Cutaneous Leishmaniasis Using Niosomal Gel of Tioxolone-Benzoxonium Chloride: In silico, in vitro, and in vivo Evaluation [PDF]
Research and Reports in Tropical MedicineMaryam Hakimi Parizi,1 Iraj Sharifi,1 Elaheh Molaakbari,1 Ehsan Salarkia,1 Mahshid Mostafavi,1 Mohammad Hossein Daie Parizi,1 Abbas Pardakhty,2 Ali Khamesipour,3 Daryoush Ghaffari11Leishmaniasis Research Center, Kerman University of Medical Sciences ...
Hakimi Parizi M +8 more
doaj +2 more sources
Spiny Hyperkeratosis-Like Follicular Mycosis Fungoides: A Case Report [PDF]
Middle East Journal of Cancer, 2023 Folliculotropic mycosis fungoides (FMF) is a rare variant of cutaneous T-cell lymphoma which is categorized as a separate entity. In histopathology, malignant lymphocytes selectively surround and infiltrate hair follicles.
Shatila Torabi +3 more
doaj +1 more source
Evaluation of clinical risk factors for systemic antimony treatment failure in patients with acute cutaneous leishmaniasis referred to dermatology clinics of Mashhad University of Medical Sciences, Iran [PDF]
Journal of Kerman University of Medical Sciences, 2023 Background: Systemic or topical form of pentavalent antimony compounds such as Meglumine Antimoniate (MA) are used as Standard treatment for cutaneous leishmaniasis (CL).
Yalda Nahidi +5 more
doaj +1 more source
Interspecies and Intrastrain Interplay among Leishmania spp. Parasites
Microorganisms, 2022 Leishmania parasites present astonishing adaptative abilities that represent a matter of life or death within disparate environments during the heteroxenous parasite life cycle.
Bruna Dias das Chagas +6 more
doaj +1 more source
Leishmania (Viannia) naiffi Lainson & Shaw 1989
Parasites & Vectors, 2023 Just over 30 years ago, a new species of Leishmania of the subgenus Leishmania (Viannia) was described infecting the armadillo Dasypus novemcinctus; then, a report of human infection followed.
Lilian Motta Cantanhêde +1 more
doaj +1 more source
Frontiers in Microbiology, 2021 Cutaneous leishmaniasis (CL) is a curable disease; however, due to various risk factors, unresponsiveness to CL treatments is inevitable. The treatment of CL has been firmly correlated with multiple determinants, such as demographical, clinical, and ...
Mehdi Bamorovat +4 more
doaj +1 more source
Microorganisms, 2023 A relevant aspect in the epidemiology of Tegumentary Leishmaniasis (TL) are the Leishmania parasites carrying a viral endosymbiont, Leishmania RNA Virus 1 (LRV1), a dsRNA virus.
Mayara Cristhine de Oliveira Santana +3 more
doaj +1 more source
Clinical Case Reports, 2021 Clinicians should always consider rare, atypical, and opportunistic infections in patients undergoing long‐term systemic corticosteroid therapy. Diagnosis needs further evaluations and special consideration.
Maryam Mahdavi +4 more
doaj +1 more source
Journal of Tropical Medicine, 2013 Visceral leishmaniasis (VL) is a parasitic disease characterized by immune suppression. Successful treatment is usually followed by immune reconstitution and a dermatosis called post-Kala-azar dermal leishmaniasis (PKDL).
Eltahir Awad Gasim Khalil +7 more
doaj +1 more source
Gates Open Research, 2019 Visceral leishmaniasis (VL) is a neglected tropical disease (NTD) caused by Leishmania protozoa that are transmitted by female sand flies. On the Indian subcontinent (ISC), VL is targeted by the World Health Organization (WHO) for elimination as a public
NTD Modelling Consortium Visceral Leishmaniasis Group
doaj +1 more source